Figure 5 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
Francisco Hermida‐Prado(Universidad de Oviedo), Rinath Jeselsohn(Dana-Farber Cancer Institute), Judith Agudo(Dana-Farber Cancer Institute), Giacomo Oliveira(Dana-Farber Cancer Institute), Alana L. Welm(Huntsman Cancer Institute), Qingchun Jin(Dana-Farber Cancer Institute), Sandro Santagata(Harvard University), Cristina Guarducci(Hospital of Prato), Tara Akhshi(Dana-Farber Cancer Institute), Irene Lee(AbbVie (United States)), Denise A. Yardley(Sarah Cannon), Marco Campisi(Dana-Farber Cancer Institute), Otto Metzger(Dana-Farber Cancer Institute), Tal Sella(Harvard University), Eugene F. Schuster(Institute of Cancer Research), Elizabeth A. Mittendorf(Beth Israel Deaconess Medical Center), Klothilda Lim(Dana-Farber Cancer Institute), Edward T. Richardson(Brigham and Women's Hospital), Zhengtao Chu(University of Utah), Xintao Qiu(Dana-Farber Cancer Institute), Minyue Chen(Dana-Farber Cancer Institute), Catherine J. Wu(Dana-Farber Cancer Institute), Douglas Russo(Dana-Farber Cancer Institute), Zsuzsanna Nagy(Dana-Farber Cancer Institute), Shira Sherman(Dana-Farber Cancer Institute), Jia‐Ren Lin(Harvard University), Agostina Nardone(AstraZeneca (Spain)), Mitch Dowsett(Institute of Cancer Research), Yingtian Xie(Dana-Farber Cancer Institute), David A. Barbie(Dana-Farber Cancer Institute), Nabihah Tayob(Dana-Farber Cancer Institute), Henry W. Long(Dana-Farber Cancer Institute), Sara M. Tolaney(Harvard University), Ingrid A. Mayer(Vanderbilt University), Juana García-Pedrero(Universidad de Oviedo), Ying Huang(Mianyang Third People's Hospital), Avery Feit(Brigham and Women's Hospital), Isabelle Bedrosian(The University of Texas MD Anderson Cancer Center), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center), Israel Cañadas(Fox Chase Cancer Center), Alba Font‐Tello(Dana-Farber Cancer Institute)
Cited by 0